Intellia Therapeutics, Inc. (NTLA)
NASDAQ: NTLA · Real-Time Price · USD
7.58
-0.09 (-1.17%)
At close: Jun 5, 2025, 4:00 PM
7.61
+0.03 (0.40%)
After-hours: Jun 5, 2025, 7:32 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Genome Editing-based Therapies
57.88M
Log In
Log In
Log In
Log In
Upgrade
Genome Editing-based Therapies Growth
59.55%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
United States
57.88M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
59.55%
Log In
Log In
Log In
Log In
Upgrade